52 Week Range
As of on the New York Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
U.S. CDC Says Delivered 400,675,525 Doses Of COVID-19 Vaccine As Of July 31
U.S. CDC Says Delivered 399,090,105 Doses Of Covid-19 Vaccine As Of July 30
FDA, Under Pressure, Plans To Accelerate Review Of Pfizer’s Covid-19 Vaccine For Full Approval - Stat News
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.
Biotechnology & Drugs
235 E 42ND ST
NEW YORK, NY
Chairman of the Board, Chief Executive Officer
John D. Young
Chief Business Officer, Group President
Frank A. D'amelio
Chief Financial Officer, Executive Vice President - Global Supply
Group President, Pfizer Biopharmaceuticals Group
Executive Vice President, Chief Technology Officer and Digital Officer
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
Pfizer Inc and Moderna Inc have raised the prices of their COVID-19 vaccines in their latest European Union supply contracts, the Financial Times reported https://on.ft.com/3j8mbTb on Sunday.
Pfizer Inc and Moderna Inc has raised the prices of its COVID-19 vaccine in the latest European Union supply contracts, The Financial Times reported https://on.ft.com/3j8mbTb on Sunday.
Pfizer Inc on Wednesday raised its 2021 sales forecast for its COVID-19 vaccine by 29% to $33.5 billion, and said it believes people will need a third dose of the shot developed with German partner BioNTech to keep protection against the virus high.
Pfizer Inc on Wednesday raised its forecast for sales of the COVID-19 vaccine that it developed with Germany's BioNTech to $33.5 billion from $26 billion, the second increase this year in the face of a global scramble for the shots. (Reporting by Manas Mishra in Bengaluru...
Italian regulators approved the use of Moderna's COVID-19 vaccine for children 12-17 years old, making it the second shot endorsed for adolescents, alongside that of Pfizer.
Moderna Inc is in talks with U.S. regulators to expand the size of an ongoing trial testing its COVID-19 vaccines in children aged between five and 11, the drugmaker said on Monday.
U.S. regulators have asked Pfizer Inc -BioNTech and Moderna Inc to expand the size of ongoing trials testing their COVID-19 vaccines in children aged between five and 11, the New York Times reported on Monday.
A mixed vaccination of first AstraZeneca and then a Pfizer COVID-19 shot boosted neutralizing antibody levels by six times compared with two AstraZeneca doses, a study from South Korea showed.
Pfizer Inc and German partner BioNTech said on Friday the U.S. government has purchased 200 million additional doses of their COVID-19 vaccine to help with pediatric vaccination as well as possible booster shots - if they are needed.
Australia's drug regulator has approved Pfizer's COVID-19 vaccine for use with 12 to 15-year-olds, Federal Health Minister Greg Hunt said on Friday, as the country fights an outbreak of the Delta variant in three states.
Pfizer and BioNTech have struck a deal for South Africa's Biovac Institute to help manufacture around 100 million doses a year of their COVID-19 vaccine for the African Union, the firms said on Wednesday.
Norway on Wednesday signed a deal to swap 100,000 doses of its unused shots made by Johnson & Johnson with Lithuania in return for an equal number of doses from Pfizer in a move to speed up inoculations.
The U.S. drug regulator said on Friday it will temporarily allow manufacturers to distribute the anti-smoking drug varenicline with elevated levels of an impurity that may cause cancer, to maintain availability after Pfizer Inc halted distribution of its Chantix branded...
The U.S. drug regulator said on Friday it will temporarily allow manufacturers to distribute versions of Pfizer Inc's anti-smoking drug Chantix with elevated levels of an impurity that may cause cancer, in order to maintain supplies.
Here is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
The U.S. health regulator will review Pfizer and German partner BioNTech SE's application for full approval of their COVID-19 vaccine in people 16 years and older by January, the companies said on Friday.
Pfizer Inc has agreed to pay $345 million to resolve claims by consumers who say they overpaid for EpiPens due to anticompetitive practices by the drugmaker and the company that markets the emergency allergy treatment, Mylan.
Pfizer Inc has agreed to pay $345 million to resolve claims by consumers who claim they overpaid for EpiPens due to anticompetitive and unfair practices by the drugmaker and the company that markets the emergency allergy treatment, Mylan.
Pfizer and Germany's BioNTech denied on Thursday that they were in talks with Thailand's Thonburi Healthcare Group Pcl for a deal to import 20 million doses of the coronavirus vaccine to the Southeast Asian country.
Panama's Health Ministry said on Monday it would allow emergency use of the Pfizer Inc-BioNTech vaccine against COVID-19 for children aged 12 years and older but gave no details on when it would start.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.